AIV Logo AIV Assistant

Loading...

Logo Revive Therapeutics Ltd. - RVVTF Open Revive Therapeutics Ltd. in new tab

0.01 USD
EPS
-0.01
P/B
1.56
ROE
-50.76
Beta
1.64

0.0090 USD

0.009 USD

Daily: +4.65%
Key Metrics

Earnings date: Nov. 27, 2025

EPS: -0.01

Book Value: 0.01

Price to Book: 1.56

% Insiders: 1.512%

DCF Valuation

Tweak assumptions to recompute fair value for Revive Therapeutics Ltd. (RVVTF)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Logo About Revive Therapeutics Ltd. - (RVVTF)

Country: Canada

Sector: Health Care

Website: http://www.revivethera.com

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.

Exchange Ticker
FRA (Germany) 31R.F
CNQ (Canada) RVV.CN
PNK (United States) RVVTF

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion